Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.
Serruys PW, Farooq V, Vranckx P, Girasis C, Brugaletta S, Garcia-Garcia HM, Holmes DR Jr, Kappetein AP, Mack MJ, Feldman T, Morice MC, Ståhle E, James S, Colombo A, Pereda P, Huang J, Morel MA, Van Es GA, Dawkins KD, Mohr FW, Steyerberg EW. Serruys PW, et al. Among authors: morel ma. JACC Cardiovasc Interv. 2012 Jun;5(6):606-17. doi: 10.1016/j.jcin.2012.03.016. JACC Cardiovasc Interv. 2012. PMID: 22721655 Free article. Clinical Trial.
Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study Group.
Macaya C, Serruys PW, Ruygrok P, Suryapranata H, Mast G, Klugmann S, Urban P, den Heijer P, Koch K, Simon R, Morice MC, Crean P, Bonnier H, Wijns W, Danchin N, Bourdonnec C, Morel MA. Macaya C, et al. Among authors: morel ma. J Am Coll Cardiol. 1996 Feb;27(2):255-61. doi: 10.1016/0735-1097(95)00473-4. J Am Coll Cardiol. 1996. PMID: 8557891 Free article. Clinical Trial.
Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study.
Serruys PW, Emanuelsson H, van der Giessen W, Lunn AC, Kiemeney F, Macaya C, Rutsch W, Heyndrickx G, Suryapranata H, Legrand V, Goy JJ, Materne P, Bonnier H, Morice MC, Fajadet J, Belardi J, Colombo A, Garcia E, Ruygrok P, de Jaegere P, Morel MA. Serruys PW, et al. Among authors: morel ma. Circulation. 1996 Feb 1;93(3):412-22. doi: 10.1161/01.cir.93.3.412. Circulation. 1996. PMID: 8565157 Clinical Trial.
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II).
Serruys PW, van Hout B, Bonnier H, Legrand V, Garcia E, Macaya C, Sousa E, van der Giessen W, Colombo A, Seabra-Gomes R, Kiemeneij F, Ruygrok P, Ormiston J, Emanuelsson H, Fajadet J, Haude M, Klugmann S, Morel MA. Serruys PW, et al. Among authors: morel ma. Lancet. 1998 Aug 29;352(9129):673-81. doi: 10.1016/s0140-6736(97)11128-x. Lancet. 1998. PMID: 9728982 Clinical Trial.
Heparin-coating of coronary stents.
van der Giessen WJ, van Beusekom HM, Eijgelshoven MH, Morèl MA, Serruys PW. van der Giessen WJ, et al. Among authors: morel ma. Semin Interv Cardiol. 1998 Sep-Dec;3(3-4):173-6. Semin Interv Cardiol. 1998. PMID: 10406689 Review.
The ARTS study (Arterial Revascularization Therapies Study).
Serruys PW, Unger F, van Hout BA, van den Brand MJ, van Herwerden LA, van Es GA, Bonnier JJ, Simon R, Cremer J, Colombo A, Santoli C, Vandormael M, Marshall PR, Madonna O, Firth BG, Breeman A, Morel MA, Hugenholtz PG. Serruys PW, et al. Among authors: morel ma. Semin Interv Cardiol. 1999 Dec;4(4):209-19. doi: 10.1006/siic.1999.0107. Semin Interv Cardiol. 1999. PMID: 10738354 Clinical Trial.
140 results